Table 1.
General characteristics of the patients
| Characteristics | Combined arm (%) | Single NP arm (%) | P |
|---|---|---|---|
| No. cases | 38 | 36 | — |
| Sex | |||
| Male | 20 (52.6) | 20 (55.6) | 0.820 |
| Female | 18 (47.4) | 16 (44.4) | |
| Age (years) | |||
| Median | 56.37 | 58.86 | 0.326 |
| Range | 35–74 | 25–75 | |
| Histology | |||
| Adenocarcinoma | 23 (60.5) | 22 (61.1) | 0.946 |
| Squamous cell carcinoma | 11 (28.9) | 11 (30.6) | |
| Other | 4 (10.5) | 3 (8.3) | |
| TNM stage | |||
| IIIB | 16 (42.1) | 11 (30.6) | 0.342 |
| IV | 22 (57.9) | 25 (69.4) | |
| Prior therapy | |||
| No | 24 (63.2) | 24 (66.7) | 0.811 |
| Yes | 14 (36.8) | 12 (33.3) | |
| ECOG | |||
| 1 | 35 (92.1) | 32 (88.9) | 0.707 |
| 2 | 3 (7.9) | 4 (11.1) | |
All prior therapies were performed using non‐standard single drug chemotherapy excluding vinorelbine and cisplatin. ECOG, Eastern Cooperative Oncology Group; NP, Navelbine and platinum.
—, unavailable.